I have posted this New York Times article previously, but it is a key article to read regarding sources of API. U.S. Concern Over Compounders Predates Outbreak of Meningitis. For example, this article states:
And records of F.D.A. drug seizures at United States borders, as well as several criminal cases, point to a link between drug compounders and Chinese manufacturers, some not registered with the F.D.A. Records analyzed by The New York Times show that in 62 cases over the last decade, the F.D.A. blocked the importation of drugs for use in compounding; nearly half were from China, one of the largest producers of raw pharmaceutical ingredients, where many manufacturers operate outside the regulatory net.
One of the previous comments to one of my blog post pointed out some of the good suppliers versus some of the bad suppliers of raw pharmaceutical ingredients, which is a reminder to everyone that knowledge of where the ingredients that go into a compounded medication comes from is critical.
No comments:
Post a Comment